Peripartum cardiomyopathy (PCMP) is characterized by severe systolic dysfunction of the heart, manifesting with signs and symptoms of heart failure in the last month of pregnancy or within the first five months postpartum in women with no previously known heart disease. A childhood-age pregnancy mother who presented to our emergency department at 3 months postpartum with complaints of dyspnea, orthopnea, edema, and palpitations. Following the diagnosis of PCMP, standard cardiomyopathy treatment was initiated alongside bromocriptine therapy. However, during follow-up, the patient died due to heart failure. PCMP, which is rare even in adult patients, can also occur in the pediatric age group. The using bromocriptine, which pediatric cardiologists may be less familiar with, in addition to standard heart failure therapy is needed to cure it, but the nature of the disease could be very severe.
Abstract. 
Background: Peripartum cardiomyopathy (PCMP) is characterized by severe systolic dysfunction of the heart, manifesting with signs and symptoms of heart failure in the last month of pregnancy or within the first five months postpartum in women with no previously known heart disease. Methods: A childhood-age pregnancy mother who presented to our emergency department at 3 months postpartum with complaints of dyspnea, orthopnea, edema, and palpitations. Following the diagnosis of PCMP, standard cardiomyopathy treatment was initiated alongside bromocriptine therapy. However, during follow-up, the patient died due to heart failure. PCMP, which is rare even in adult patients, can also occur in the pediatric age group. The using bromocriptine, which pediatric cardiologists may be less familiar with, in addition to standard heart failure therapy is needed to cure it, but the nature of the disease could be very severe.
Etik kurallara vaka sunumu sırasında uyulmuştur
yok
yayınlanması için değerlendirilmesine teşekkür ederim
| Birincil Dil | İngilizce | 
|---|---|
| Konular | Klinik Tıp Bilimleri (Diğer) | 
| Bölüm | Case Report | 
| Yazarlar | |
| Yayımlanma Tarihi | 28 Ekim 2025 | 
| Gönderilme Tarihi | 26 Nisan 2025 | 
| Kabul Tarihi | 23 Haziran 2025 | 
| Yayımlandığı Sayı | Yıl 2025 Cilt: 35 Sayı: 5 | 
Genel Tıp Dergisi Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı (CC BY NC) ile lisanslanmıştır.